Genetic nature and virulence of community-associated methicillin-resistant Staphylococcus aureus

BioMedicine (Netherlands)

Volumn 3, Issue 1, 2013, Pages 2-18

  Yamamoto, Tatsuo ^a,b   Hung, Wei Chun ^a,b   Takano, Tomomi ^b   Nishiyama, Akihito ^b  

^a International Medical Education and Research Center   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Community acquired methicillin resistant Staphylococcus aureus (MRSA); Drug resistance; Evolution; MRSA community acquired diseases; Virulence factor

Indexed keywords

CELL SURFACE PROTEIN;

BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL LINEAGE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EVOLUTIONARY ADAPTATION; GENE CASSETTE; GENE MUTATION; GENETIC CONSERVATION; GENETIC RISK; GENOME ANALYSIS; GENOTYPE; HUMAN; IMMUNE EVASION; MEC GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIAL COMMUNITY; MULTIDRUG RESISTANCE; NONHUMAN; NOSE CAVITY; PRIORITY JOURNAL; REVIEW;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84875259470     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2012.12.001     Document Type: Review

References (187)

1. Bryskier A. Penicillins. Antimicrobial agents: antibacterials and antifungals 2005, 113-162. ASM Press, Washington, DC. A. Bryskier (Ed.).
2. Lacey R.W. Genetic basis, epidemiology, and future significance of antibiotic resistance in Staphylococcus aureus: a review. J Clin Pathol 1973, 26:899-913.
3. Lyon B.R., Skurray R. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev 1987, 51:88-134.
4. Lacey R.W. Antibiotic resistance plasmids of Staphylococcus aureus and their clinical importance. Bacteriol Rev 1975, 39:1-32.
5. Brumfitt W., Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989, 320:1188-1196.
6. Shimada K. Methicillin-resistant Staphylococcus aureus. Nihon Rinsho 1986, 44:2112-2121. [In Japanese].
7. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 1999, 48:707-710. Centers for Disease Control and Prevention C.
8. Community-acquired methicillin-resistant Staphylococcus aureus infections-Michigan. MMWR Morb Mortal Wkly Rep 1981, 30:185-187. Centers for Disease Control and Prevention C.
9. Noto M.J., Kreiswirth B.N., Monk A.B., Archer G.L. Gene acquisition at the insertion site for SCCmec, the genomic island conferring methicillin resistance in Staphylococcus aureus. J Bacteriol 2008, 190:1276-1283.
10. Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 2009, 53:4961-4967. International working group on the classification of staphylococcal cassette chromosome elements.
11. Hartman B.J., Tomasz A. Low-affinity penicillin-binding protein associated with â-lactam resistance in Staphylococcus aureus. J Bacteriol 1984, 158:513-516.
12. Fuda C., Suvorov M., Vakulenko S.B., Mobashery S. The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J Biol Chem 2004, 279:40802-40806.
13. Performance standard for antimicrobial susceptibility testing; 21st informational supplement 2011, Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA.
14. Aires de Sousa M., Conceição T., Simas C., de Lencastre H. Comparison of genetic backgrounds of methicillin-resistant and -susceptible Staphylococcus aureus isolates from Portuguese hospitals and the community. J Clin Microbiol 2005, 43:5150-5157.
15. Enright M.C., Robinson D.A., Randle G., Feil E.J., Grundmann H., Spratt B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002, 99:7687-7692.
16. Oliveira D.C., Tomasz A., de Lencastre H. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb Drug Resist 2001, 7:349-361.
17. Tanaka T., Okuzumi K., Iwamoto A., Hiramatsu K. A retrospective study of methicillin-resistant Staphylococcus aureus clinical strains in Tokyo university hospital. J Infect Chemother 1995, 1:40-49.
18. de Lencastre H., Severina E.P., Roberts R.B., Kreiswirth B.N., Tomasz A., The BARG Initiative Pilot Study Group, et al. Testing the efficacy of a molecular surveillance network: methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF) genotypes in six hospitals in the metropolitan New York City area. Microb Drug Resist 1996, 2:343-351.
19. Roberts R.B., Chung M., de Lencastre H., Hargrave J., Tomasz A., Nicolau D.P., et al. Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. Microb Drug Resist 2000, 6:245-251.
20. Aires de Sousa M., de Lencastre H., Santos Sanches I., Kikuchi K., Totsuka K., Tomasz A. Similarity of antibiotic resistance patterns and molecular typing properties of methicillin-resistant Staphylococcus aureus isolates widely spread in hospitals in New York City and in a hospital in Tokyo, Japan. Microb Drug Resist 2000, 6:253-258.
21. Oliveira D.C., Tomasz A., de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002, 2:180-189.
22. Diep B.A., Carleton H.A., Chang R.F., Sensabaugh G.F., Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 2006, 193:1495-1503.
23. Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001, 357:1225-1240.
24. Takano T., Higuchi W., Otsuka T., Baranovich T., Enany S., Saito K., et al. Novel characteristics of community-acquired methicillin-resistant Staphylococcus aureus strains belonging to multilocus sequence type 59 in Taiwan. Antimicrob Agents Chemother 2008, 52:837-845.
25. Huang Y.C., Su L.H., Wu T.L., Lin T.Y. Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates from a teaching hospital in Northern Taiwan. J Clin Microbiol 2006, 44:2268-2270.
26. Oliveira D., Santos-Sanches I., Mato R., Tamayo M., Ribeiro G., Costa D., et al. Virtually all methicillin-resistant Staphylococcus aureus (MRSA) infections in the largest Portuguese teaching hospital are caused by two internationally spread multiresistant strains: the 'Iberian' and the 'Brazilian' clones of MRSA. Clin Microbiol Infect 1998, 4:373-384.
27. Aires de Sousa M., Sanches I.S., Ferro M.L., Vaz M.J., Saraiva Z., Tendeiro T., et al. Intercontinental spread of a multidrug-resistant methicillin-resistant Staphylococcus aureus clone. J Clin Microbiol 1998, 36:2590-2596.
28. Harris S.R., Feil E.J., Holden M.T., Quail M.A., Nickerson E.K., Chantratita N., et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010, 327:469-474.
29. Edgeworth J.D., Yadegarfar G., Pathak S., Batra R., Cockfield J.D., Wyncoll D., et al. An outbreak in an intensive care unit of a strain of methicillin-resistant Staphylococcus aureus sequence type 239 associated with an increased rate of vascular access device-related bacteremia. Clin Infect Dis 2007, 44:493-501.
30. Yamamoto T., Takano T., Higuchi W., Iwao Y., Singur O., Reva I., et al. Comparative genomics and drug resistance of a geographic variant of ST239 methicillin-resistant Staphylococcus aureus emerged in Russia. PLoS One 2012, 7:e29187.
31. Chen C.J., Hsueh P.R., Su L.H., Chiu C.H., Lin T.Y., Huang Y.C. Change in the molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream infections in Taiwan. Diagn Microbiol Infect Dis 2009, 65:199-201.
32. Chen C.M., Huang M., Chen H.F., Ke S.C., Li C.R., Wang J.H., et al. Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital. BMC Microbiol 2011, 11:98.
33. Chen H.J., Hung W.C., Tseng S.P., Tsai J.C., Hsueh P.R., Teng L.J. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother 2010, 54:4985-4991.
34. Iwao Y., Khokhlova O.E., Takano T., Hung W.C., Isobe H., Peryanova O.V., et al. Fatal pneumonia in HIV-infected patients from a novel ST239 methicillin-resistant Staphylococcus aureus carrying the toxic shock syndrome toxin-1 gene in Krasnoyarsk, Siberian Russia. Jpn J Infect Dis 2012, 65:184-186.
35. Diep B.A., Otto M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol 2008, 16:361-369.
36. Zetola N., Francis J.S., Nuermberger E.L., Bishai W.R. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005, 5:275-286.
37. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003, 9:978-984.
38. Tenover F.C., McDougal L.K., Goering R.V., Killgore G., Projan S.J., Patel J.B., et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 2006, 44:108-118.
39. Huang Y.C., Ho C.F., Chen C.J., Su L.H., Lin T.Y. Comparative molecular analysis of community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus isolates from children in northern Taiwan. Clin Microbiol Infect 2008, 14:1167-1172.
40. Grundmann H., Aires-de-Sousa M., Boyce J., Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006, 368:874-885.
41. Diep B.A., Stone G.G., Basuino L., Graber C.J., Miller A., des Etages S.A., et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 2008, 197:1523-1530.
42. Hung W.C., Takano T., Higuchi W., Iwao Y., Khokhlova O., Teng L.J., et al. Comparative genomics of community-acquired ST59 methicillin-resistant Staphylococcus aureus in Taiwan: novel mobile resistance structures with IS1216V. PLoS One 2012, 7:e46987.
43. Takano T., Higuchi W., Yamamoto T. Superior in vitro activity of carbapenems over anti-methicillin-resistant Staphylococcus aureus (MRSA) and some related antimicrobial agents for community-acquired MRSA but not for hospital-acquired MRSA. J Infect Chemother 2009, 15:54-57.
44. Tenover F.C., Goering R.V. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 2009, 64:441-446.
45. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
46. Miller L.G., Diep B.A. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008, 46:752-760.
47. Nimmo G.R. USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2012, 18:725-734.
48. Shibuya Y., Hara M., Higuchi W., Takano T., Iwao Y., Yamamoto T. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in Japan. J Infect Chemother 2008, 14:439-441.
49. Rolo J., Miragaia M., Turlej-Rogacka A., Empel J., Bouchami O., Faria N.A., et al. High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study. PLoS One 2012, 7:e34768s.
50. Otter J.A., French G.L. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010, 10:227-239.
51. Diep B.A., Gill S.R., Chang R.F., Phan T.H., Chen J.H., Davidson M.G., et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006, 367:731-739.
52. Wang C.C., Lo W.T., Chu M.L., Siu L.K. Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis 2004, 39:481-487.
53. Lo W.T., Lin W.J., Tseng M.H., Wang S.R., Chu M.L., Wang C.C. Methicillin-resistant Staphylococcus aureus in children, Taiwan. Emerg Infect Dis 2006, 12:1267-1270.
54. T or SCCmec type IV. J Clin Microbiol 2005, 43:4719-4730.
55. Chen C.J., Hsu K.H., Lin T.Y., Hwang K.P., Chen P.Y., Huang Y.C. Factors associated with nasal colonization of methicillin-resistant Staphylococcus aureus among healthy children in Taiwan. J Clin Microbiol 2011, 49:131-137.
56. Huang Y.C., Hwang K.P., Chen P.Y., Chen C.J., Lin T.Y. Prevalence of methicillin-resistant Staphylococcus aureus nasal colonization among Taiwanese children in 2005 and 2006. J Clin Microbiol 2007, 45:3992-3995.
57. Wang J.T., Liao C.H., Fang C.T., Chie W.C., Lai M.S., Lauderdale T.L., et al. Prevalence of and risk factors for colonization by methicillin-resistant Staphylococcus aureus among adults in community settings in Taiwan. J Clin Microbiol 2009, 47:2957-2963.
58. Huang Y.H., Tseng S.P., Hu J.M., Tsai J.C., Hsueh P.R., Teng L.J. Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital. Clin Microbiol Infect 2007, 13:717-724.
59. Hsieh J.M., Chen R.S., Tsai T.Y., Pan T.M., Chou C.C. Phylogenetic analysis of livestock oxacillin-resistant Staphylococcus aureus. Vet Microbiol 2008, 126:234-242.
60. Wan M.T., Fu S.Y., Lo Y.P., Huang T.M., Cheng M.M., Chou C.C. Heterogeneity and phylogenetic relationships of community-associated methicillin-sensitive/resistant Staphylococcus aureus isolates in healthy dogs, cats and their owners. J Appl Microbiol 2012, 112:205-213.
61. Higuchi W., Hung W.C., Takano T., Iwao Y., Ozaki K., Isobe H., et al. Molecular characteristics of the Taiwanese multiple drug-resistant ST59 clone of Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from pediatric cellulitis. J Infect Chemother 2010, 16:144-149.
62. Takizawa Y., Taneike I., Nakagawa S., Oishi T., Nitahara Y., Iwakura N., et al. A Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. J Clin Microbiol 2005, 43:3356-3363.
63. Iwao Y., Ishii R., Tomita Y., Shibuya Y., Takano T., Hung W.C., et al. The emerging ST8 methicillin-resistant Staphylococcus aureus clone in the community in Japan: associated infections, genetic diversity, and comparative genomics. J Infect Chemother 2012, 18:228-240.
64. Iwao Y., Yabe S., Takano T., Higuchi W., Nishiyama A., Yamamoto T. Isolation and molecular characterization of methicillin-resistant Staphylococcus aureus from public transport. Microbiol Immunol 2012, 56:76-82.
65. David M.Z., Daum R.S. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010, 23:616-687.
66. Dedent A.C., Marraffini L.A., Schneewind O. Staphylococcal sortase and surface proteins. Gram-positive pathogen 2006, 486-495. ASM Press, Washington, DC. 2nd ed. V.A. Fischetti, R.P. Novick, J.J. Ferretti, D.A. Potnoy, J.I. Rood (Eds.).
67. Iwao Y., Takano T., Higuchi W., Yamamoto T. A new staphylococcal cassette chromosome mec IV encoding a novel cell-wall-anchored surface protein in a major ST8 community-acquired methicillin-resistant Staphylococcus aureus clone in Japan. J Infect Chemother 2012, 18:96-104.
68. Yamamoto T., Takano T., Yabe S., Higuchi W., Iwao Y., Isobe H., et al. Super-sticky familial infections caused by Panton-Valentine leukocidin-positive ST22 community-acquired methicillin-resistant Staphylococcus aureus in Japan. J Infect Chemother 2012, 18:187-198.
69. Yamaguchi T., Yokota Y., Terajima J., Hayashi T., Aepfelbacher M., Ohara M., et al. Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis 2002, 185:1511-1516.
70. Wang R., Braughton K.R., Kretschmer D., Bach T.H., Queck S.Y., Li M., et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007, 13:1510-1514.
71. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984.
72. Yamamoto T., Nishiyama A., Takano T., Yabe S., Higuchi W., Razvina O., et al. Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance. J Infect Chemother 2010, 16:225-254.
73. Miller L.G., Eells S.J., Taylor A.R., David M.Z., Ortiz N., Zychowski D., et al. Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clin Infect Dis 2012, 54:1523-1535.
74. Okubo T., Yabe S., Otsuka T., Takizawa Y., Takano T., Dohmae S., et al. Multifocal pelvic abscesses and osteomyelitis from community-acquired methicillin-resistant Staphylococcus aureus in a 17-year-old basketball player. Diagn Microbiol Infect Dis 2008, 60:313-318.
75. Liu C., Bayer A., Cosgrove S.E., Daum R.S., Fridkin S.K., Gorwitz R.J., et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011, 52:285-292.
76. Khokhlova O., Tomita Y., Hung W.C., Takano T., Iwao Y., Higuchi W., et al. Elderly infection in the community due to ST5/SCCmecII methicillin-resistant Staphylococcus aureus (the New York/Japan clone) in Japan: Panton-Valentine leukocidin-negative necrotizing pneumonia. J Microbiol Immunol Infect 2012, 10.1016/j.jmii.2012.09.004.
77. Hageman J.C., Uyeki T.M., Francis J.S., Jernigan D.B., Wheeler J.G., Bridges C.B., et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006, 12:894-899.
78. Rubinstein E., Kollef M.H., Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008, 46(Suppl. 5):S378-S385.
79. Ladhani S., Joannou C.L., Lochrie D.P., Evans R.W., Poston S.M. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev 1999, 12:224-242.
80. Shi D., Higuchi W., Takano T., Saito K., Ozaki K., Takano M., et al. Bullous impetigo in children infected with methicillin-resistant Staphylococcus aureus alone or in combination with methicillin-susceptible S. aureus: analysis of genetic characteristics, including assessment of exfoliative toxin gene carriage. J Clin Microbiol 2011, 49:1972-1974.
81. Shi D., Ishii S., Sato T., Yamazaki H., Matsunaga M., Higuchi W., et al. Staphylococcal scalded skin syndrome in an extremely low-birth-weight neonate: molecular characterization and rapid detection by multiplex and real-time PCR of methicillin-resistant Staphylococcus aureus. Pediatr Int 2011, 53:211-217.
82. Weber K. Community-associated methicillin-resistant Staphylococcus aureus infections in the athlete. Sports Health 2009, 1:405-410.
83. Malachowa N., Kobayashi S.D., DeLeo F.R. Community-associated methicillin-resistant Staphylococcus aureus and athletes. Phys Sportsmed 2012, 40:13-21.
84. Landrum M.L., Neumann C., Cook C., Chukwuma U., Ellis M.W., Hospenthal D.R., et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 2012, 308:50-59.
85. Patel M., Kumar R.A., Stamm A.M., Hoesley C.J., Moser S.A., Waites K.B. USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections. J Clin Microbiol 2007, 45:3431-3433.
86. Demling R.H., Waterhouse B. The increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by methicillin-resistant Staphylococcus aureus. J Burns Wounds 2007, 7:e8.
87. del Rio A., Cervera C., Moreno A., Moreillon P., Miró J.M. Patients at risk of complications of Staphylococcus aureus bloodstream infection. Clin Infect Dis 2009, 48(Suppl. 4):S246-S253.
88. Seybold U., Kourbatova E.V., Johnson J.G., Halvosa S.J., Wang Y.F., King M.D., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006, 42:647-656.
89. Alonso C.D., Barclay S., Tao X., Auwaerter P.G. Increasing incidence of iliopsoas abscesses with MRSA as a predominant pathogen. J Infect 2011, 63:1-7.
90. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., Albrecht V., Limbago B., et al. Prevalence of methicillin-resistant Staphylococcus aureus as an etiology of community-acquired pneumonia. Clin Infect Dis 2012, 54:1126-1133.
91. Randolph A.G., Vaughn F., Sullivan R., Rubinson L., Thompson B.T., Yoon G., et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 2011, 128:e1450-e1458.
92. Infectious disease and dermatologic conditions in evacuees and rescue workers after Hurricane Katrina-multiple states, August-September, 2005. MMWR Morb Mortal Wkly Rep 2005, 54:961-964. Centers for Disease Control and Prevention C.
93. Larsson A.K., Gustafsson E., Nilsson A.C., Odenholt I., Ringberg H., Melander E. Duration of methicillin-resistant Staphylococcus aureus colonization after diagnosis: a four-year experience from southern Sweden. Scand J Infect Dis 2011, 43:456-462.
94. Yabe S., Takano T., Higuchi W., Mimura S., Kurosawa Y., Yamamoto T. Spread of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone among family members in Japan. J Infect Chemother 2010, 16:372-374.
95. Higuchi W., Mimura S., Kurosawa Y., Takano T., Iwao Y., Yabe S., et al. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in a Japanese child, demonstrating multiple divergent strains in Japan. J Infect Chemother 2010, 16:292-297.
96. Ozaki K., Takano M., Higuchi W., Takano T., Yabe S., Nitahara Y., et al. Genotypes, intrafamilial transmission, and virulence potential of nasal methicillin-resistant Staphylococcus aureus from children in the community. J Infect Chemother 2009, 15:84-91.
97. Hisata K., Kuwahara-Arai K., Yamanoto M., Ito T., Nakatomi Y., Cui L., et al. Dissemination of methicillin-resistant staphylococci among healthy Japanese children. J Clin Microbiol 2005, 43:3364-3372.
98. Lo W.T., Wang C.C., Lin W.J., Wang S.R., Teng C.S., Huang C.F., et al. Changes in the nasal colonization with methicillin-resistant Staphylococcus aureus in children: 2004-2009. PLoS One 2010, 5:e15791.
99. Huang Y.C., Chen C.J. Community-associated meticillin-resistant Staphylococcus aureus in children in Taiwan, 2000s. Int J Antimicrob Agents 2011, 38:2-8.
100. Ito T., Hiramatsu K., Tomasz A., de Lencastre H., Perreten V., Holden M.T., et al. Guidelines for Reporting Novel mecA Gene Homologues. Antimicrob Agents Chemother 2012, 56:4997-4999.
101. Shore A.C., Rossney A.S., Brennan O.M., Kinnevey P.M., Humphreys H., Sullivan D.J., et al. Characterization of a novel arginine catabolic mobile element (ACME) and staphylococcal chromosomal cassette mec composite island with significant homology to Staphylococcus epidermidis ACME type II in methicillin-resistant Staphylococcus aureus genotype ST22-MRSA-IV. Antimicrob Agents Chemother 2011, 55:1896-1905.
102. Ito T., Okuma K., Ma X.X., Yuzawa H., Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat 2003, 6:41-52.
103. Isobe H., Takano T., Nishiyama A., Hung W.C., Kuniyuki S., Shibuya Y., et al. Evolution and virulence of Panton-Valentine leukocidin-positive ST30 methicillin-resistant Staphylococcus aureus in the past 30 years in Japan. Biomed Res 2012, 33:97-109.
104. Li S., Skov R.L., Han X., Larsen A.R., Larsen J., Sørum M., et al. Novel types of staphylococcal cassette chromosome mec elements identified in clonal complex 398 methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2011, 55:3046-3050.
105. Takano T., Hung W.C., Shibuya M., Higuchi W., Iwao Y., Nishiyama A., et al. A New Local Variant (ST764) of the Globally-Disseminated ST5 Lineage of Hospital-Associated Methicillin-Resistant Staphylococcus aureus (MRSA), Carrying the Virulence Determinants of Community-Associated MRSA. Antimicrob Agents Chemother 2013 Jan 14, [Epub ahead of print].
106. García-álvarez L., Holden M.T., Lindsay H., Webb C.R., Brown D.F., Curran M.D., et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis 2011, 11:595-603.
107. Laurent F., Chardon H., Haenni M., Bes M., Reverdy M.E., Madec J.Y., et al. MRSA Harboring mecA Variant Gene mecC, France. Emerg Infect Dis 2012, 18:1465-1467.
108. Higuchi W., Takano T., Teng L.J., Yamamoto T. Structure and specific detection of staphylococcal cassette chromosome mec type VII. Biochem Biophys Res Commun 2008, 377:752-756.
109. Chlebowicz M.A., van Dijl J.M., Buist G. Considerations for the distinction of ccrC-containing staphylococcal cassette chromosome mec elements. Antimicrob Agents Chemother 2011, 55:1823-1824.
110. Urushibara N., Kawaguchiya M., Kobayashi N. Two novel arginine catabolic mobile elements and staphylococcal chromosome cassette mec composite islands in community-acquired methicillin-resistant Staphylococcus aureus genotypes ST5-MRSA-V and ST5-MRSA-II. J Antimicrob Chemother 2012, 67:1828-1834.
111. Bartels M.D., Hansen L.H., Boye K., Sørensen S.J., Westh H. An unexpected location of the arginine catabolic mobile element (ACME) in a USA300-related MRSA strain. PLoS One 2011, 6:e16193.
112. Espedido B.A., Steen J.A., Barbagiannakos T., Mercer J., Paterson D.L., Grimmond S.M., et al. Carriage of an ACME II variant may have contributed to methicillin-resistant Staphylococcus aureus sequence type 239-like strain replacement in Liverpool Hospital, Sydney, Australia. Antimicrob Agents Chemother 2012, 56:3380-3383.
113. Savolainen K., Paulin L., Westerlund-Wikström B., Foster T.J., Korhonen T.K., Kuusela P. Expression of pls, a gene closely associated with the mecA gene of methicillin-resistant Staphylococcus aureus, prevents bacterial adhesion in vitro. Infect Immun 2001, 69:3013-3020.
114. Juuti K.M., Sinha B., Werbick C., Peters G., Kuusela P.I. Reduced adherence and host cell invasion by methicillin-resistant Staphylococcus aureus expressing the surface protein Pls. J Infect Dis 2004, 189:1574-1584.
115. Queck S.Y., Khan B.A., Wang R., Bach T.H., Kretschmer D., Chen L., et al. Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog 2009, 5:e1000533.
116. Chatterjee S.S., Chen L., Joo H.S., Cheung G.Y., Kreiswirth B.N., Otto M. Distribution and regulation of the mobile genetic element-encoded phenol-soluble modulin PSM-mec in methicillin-resistant Staphylococcus aureus. PLoS One 2011, 6:e28781.
117. McDougal L.K., Fosheim G.E., Nicholson A., Bulens S.N., Limbago B.M., Shearer J.E., et al. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob Agents Chemother 2010, 54:3804-3811.
118. Shore A.C., Brennan O.M., Ehricht R., Monecke S., Schwarz S., Slickers P., et al. Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate. Antimicrob Agents Chemother 2010, 54:4978-4984.
119. Stegger M., Price L.B., Larsen A.R., Gillece J.D., Waters A.E., Skov R., et al. Genome sequence of Staphylococcus aureus strain 11819-97, an ST80-IV European community-acquired methicillin-resistant isolate. J Bacteriol 2012, 194:1625-1626.
120. Harraghy N., Hussain M., Haggar A., Chavakis T., Sinha B., Herrmann M., et al. The adhesive and immunomodulating properties of the multifunctional Staphylococcus aureus protein Eap. Microbiology 2003, 149:2701-2707.
121. Li M., Du X., Villaruz A.E., Diep B.A., Wang D., Song Y., et al. MRSA epidemic linked to a quickly spreading colonization and virulence determinant. Nat Med 2012, 18:816-819.
122. Tung H., Guss B., Hellman U., Persson L., Rubin K., Rydén C. A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochem J 2000, 345:611-619.
123. de Bentzmann S., Tristan A., Etienne J., Brousse N., Vandenesch F., Lina G. Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J Infect Dis 2004, 190:1506-1515.
124. Gonzalez B.E., Hulten K.G., Dishop M.K., Lamberth L.B., Hammerman W.A., Mason E.O., et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 2005, 41:583-590.
125. Grundmeier M., Hussain M., Becker P., Heilmann C., Peters G., Sinha B. Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function. Infect Immun 2004, 72:7155-7163.
126. Nishiyama A., Isobe H., Iwao Y., Takano T., Hung W.C., Taneike I., et al. Accumulation of staphylococcal Panton-Valentine leukocidin in the detergent-resistant membrane microdomains on the target cells is essential for its cytotoxicity. FEMS Immunol Med Microbiol 2012, 66:343-352.
127. Löffler B., Hussain M., Grundmeier M., Brück M., Holzinger D., Varga G., et al. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 2010, 6:e1000715.
128. Kaneko J., Kamio Y. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 2004, 68:981-1003.
129. Morinaga N., Kaihou Y., Noda M. Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family. Microbiol Immunol 2003, 47:81-90.
130. Matic G., Bosch T., Ramlow W. Background and indications for protein A-based extracorporeal immunoadsorption. Ther Apher 2001, 5:394-403.
131. Giese B., Glowinski F., Paprotka K., Dittmann S., Steiner T., Sinha B., et al. Expression of δ-toxin by Staphylococcus aureus mediates escape from phago-endosomes of human epithelial and endothelial cells in the presence of β-toxin. Cell Microbiol 2011, 13:316-329.
132. de Haas C.J., Veldkamp K.E., Peschel A., Weerkamp F., Van Wamel W.J., Heezius E.C., et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004, 199:687-695.
133. Rooijakkers S.H., Ruyken M., Roos A., Daha M.R., Presanis J.S., Sim R.B., et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 2005, 6:920-927.
134. Yokoyama R., Itoh S., Kamoshida G., Takii T., Fujii S., Tsuji T., et al. Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages. Infect Immun 2012, 80:2816-2825.
135. Itoh S., Hamada E., Kamoshida G., Takeshita K., Oku T., Tsuji T. Staphylococcal superantigen-like protein 5 inhibits matrix metalloproteinase 9 from human neutrophils. Infect Immun 2010, 78:3298-3305.
136. Langley R., Wines B., Willoughby N., Basu I., Proft T., Fraser J.D. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol 2005, 174:2926-2933.
137. Itoh S., Hamada E., Kamoshida G., Yokoyama R., Takii T., Onozaki K., et al. Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway. Mol Immunol 2010, 47:932-938.
138. Chung M.C., Wines B.D., Baker H., Langley R.J., Baker E.N., Fraser J.D. The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol Microbiol 2007, 66:1342-1355.
139. Kobayashi S.D., Malachowa N., Whitney A.R., Braughton K.R., Gardner D.J., Long D., et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 2011, 204:937-941.
140. Nishifuji K., Sugai M., Amagai M. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci 2008, 49:21-31.
141. Bubeck Wardenburg J., Bae T., Otto M., Deleo F.R., Schneewind O. Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007, 13:1405-1406.
142. Strandberg K.L., Rotschafer J.H., Vetter S.M., Buonpane R.A., Kranz D.M., Schlievert P.M. Staphylococcal superantigens cause lethal pulmonary disease in rabbits. J Infect Dis 2010, 202:1690-1697.
143. Labandeira-Rey M., Couzon F., Boisset S., Brown E.L., Bes M., Benito Y., et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007, 315:1130-1133.
144. Diep B.A., Chan L., Tattevin P., Kajikawa O., Martin T.R., Basuino L., et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 2010, 107:5587-5592.
145. Crémieux A.C., Dumitrescu O., Lina G., Vallee C., Côté J.F., Muffat-Joly M., et al. Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One 2009, 4:e7204.
146. Schlievert P.M. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1986, 1:1149-1150.
147. Xu S.X., McCormick J.K. Staphylococcal superantigens in colonization and disease. Front Cell Infect Microbiol 2012, 2:52.
148. Takahashi N., Nishida H., Kato H., Imanishi K., Sakata Y., Uchiyama T. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 1998, 351:1614-1619.
149. Ferry T., Thomas D., Genestier A.L., Bes M., Lina G., Vandenesch F., et al. Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis 2005, 41:771-777.
150. Clarke S.R., Foster S.J. Surface adhesins of Staphylococcus aureus. Adv Microb Physiol 2006, 51:187-224.
151. Rivas J.M., Speziale P., Patti J.M., Höök M. MSCRAMM-targeted vaccines and immunotherapy for staphylococcal infection. Curr Opin Drug Discov Devel 2004, 7:223-227.
152. Chavakis T., Wiechmann K., Preissner K.T., Herrmann M. Staphylococcus aureus interactions with the endothelium: the role of bacterial "secretable expanded repertoire adhesive molecules" (SERAM) in disturbing host defense systems. Thromb Haemost 2005, 94:278-285.
153. Otto M. Staphylococcal biofilms. Curr Top Microbiol Immunol 2008, 322:207-228.
154. Tristan A., Benito Y., Montserret R., Boisset S., Dusserre E., Penin F., et al. The signal peptide of Staphylococcus aureus panton valentine leukocidin LukS component mediates increased adhesion to heparan sulfates. PLoS One 2009, 4:e5042.
155. Gómez M.I., O'Seaghdha M., Magargee M., Foster T.J., Prince A.S. Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J Biol Chem 2006, 281:20190-20196.
156. Genestier A.L., Michallet M.C., Prévost G., Bellot G., Chalabreysse L., Peyrol S., et al. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 2005, 115:3117-3127.
157. van Wamel W.J., Rooijakkers S.H., Ruyken M., van Kessel K.P., van Strijp J.A. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on β-hemolysin-converting bacteriophages. J Bacteriol 2006, 188:1310-1315.
158. Fraser J.D., Proft T. The bacterial superantigen and superantigen-like proteins. Immunol Rev 2008, 225:226-243.
159. Mertz P.M., Cardenas T.C., Snyder R.V., Kinney M.A., Davis S.C., Plano L.R. Staphylococcus aureus virulence factors associated with infected skin lesions: influence on the local immune response. Arch Dermatol 2007, 143:1259-1263.
160. Yamaguchi T., Hayashi T., Takami H., Nakasone K., Ohnishi M., Nakayama K., et al. Phage conversion of exfoliative toxin A production in Staphylococcus aureus. Mol Microbiol 2000, 38:694-705.
161. Yamaguchi T., Hayashi T., Takami H., Ohnishi M., Murata T., Nakayama K., et al. Complete nucleotide sequence of a Staphylococcus aureus exfoliative toxin B plasmid and identification of a novel ADP-ribosyltransferase, EDIN-C. Infect Immun 2001, 69:7760-7771.
162. Holmes A., Ganner M., McGuane S., Pitt T.L., Cookson B.D., Kearns A.M. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 2005, 43:2384-2390.
163. Yamamoto T., Dohmae S., Saito K., Otsuka T., Takano T., Chiba M., et al. Molecular characteristics and in vitro susceptibility to antimicrobial agents, including the des-fluoro(6) quinolone DX-619, of Panton-Valentine leucocidin-positive methicillin-resistant Staphylococcus aureus isolates from the community and hospitals. Antimicrob Agents Chemother 2006, 50:4077-4086.
164. Gouaux E., Hobaugh M., Song L. α-Hemolysin, γ-hemolysin, and leukocidin from Staphylococcus aureus: distant in sequence but similar in structure. Protein Sci 1997, 6:2631-2635.
165. Ventura C.L., Malachowa N., Hammer C.H., Nardone G.A., Robinson M.A., Kobayashi S.D., et al. Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS One 2010, 5:e11634.
166. Lina G., Piémont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
167. Munckhof W.J., Nimmo G.R., Carney J., Schooneveldt J.M., Huygens F., Inman-Bamber J., et al. Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis 2008, 27:355-364.
168. Tong S.Y., Lilliebridge R.A., Bishop E.J., Cheng A.C., Holt D.C., McDonald M.I., et al. Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia. J Infect Dis 2010, 202:760-769.
169. Gillet Y., Issartel B., Vanhems P., Fournet J.C., Lina G., Bes M., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359:753-759.
170. Li H.T., Zhang T.T., Huang J., Zhou Y.Q., Zhu J.X., Wu B.Q. Factors associated with the outcome of life-threatening necrotizing pneumonia due to community-acquired Staphylococcus aureus in adult and adolescent patients. Respiration 2011, 81:448-460.
171. Defres S., Marwick C., Nathwani D. MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia. Eur Respir J 2009, 34:1470-1476.
172. Niemann S., Ehrhardt C., Medina E., Warnking K., Tuchscherr L., Heitmann V., et al. Combined action of influenza virus and Staphylococcus aureus Panton-Valentine leukocidin provokes severe lung epithelium damage. J Infect Dis 2012, 206:1138-1148.
173. Bocchini C.E., Hulten K.G., Mason E.O., Gonzalez B.E., Hammerman W.A., Kaplan S.L. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 2006, 117:433-440.
174. König B., Köller M., Prevost G., Piemont Y., Alouf J.E., Schreiner A., et al. Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8. Infect Immun 1994, 62:4831-4837.
175. Zivkovic A., Sharif O., Stich K., Doninger B., Biaggio M., Colinge J., et al. TLR 2 and CD14 mediate innate immunity and lung inflammation to staphylococcal Panton-Valentine leukocidin in vivo. J Immunol 2011, 186:1608-1617.
176. Kaneko J., Kimura T., Narita S., Tomita T., Kamio Y. Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage PVL carrying Panton-Valentine leukocidin genes. Gene 1998, 215:57-67.
177. Diep B.A., Palazzolo-Ballance A.M., Tattevin P., Basuino L., Braughton K.R., Whitney A.R., et al. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One 2008, 3:e3198.
178. Bantel H., Sinha B., Domschke W., Peters G., Schulze-Osthoff K., Jänicke R.U. α-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol 2001, 155:637-648.
179. Forsman H., Christenson K., Bylund J., Dahlgren C. Receptor-dependent and -independent immunomodulatory effects of phenol-soluble modulin peptides from Staphylococcus aureus on human neutrophils are abrogated through peptide inactivation by reactive oxygen species. Infect Immun 2012, 80:1987-1995.
180. Ono H.K., Omoe K., Imanishi K., Iwakabe Y., Hu D.L., Kato H., et al. Identification and characterization of two novel staphylococcal enterotoxins, types S and T. Infect Immun 2008, 76:4999-5005.
181. Vojtov N., Ross H.F., Novick R.P. Global repression of exotoxin synthesis by staphylococcal superantigens. Proc Natl Acad Sci USA 2002, 99:10102-10107.
182. Novick R.P. Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 2003, 49:93-105.
183. Yarwood J.M., McCormick J.K., Paustian M.L., Orwin P.M., Kapur V., Schlievert P.M. Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. J Biol Chem 2002, 277:13138-13147.
184. Ito T., Iijima M., Fukushima T., Nonoyama M., Ishii M., Baranovich T., et al. Pediatric pneumonia death caused by community-acquired methicillin-resistant Staphylococcus aureus, Japan. Emerg Infect Dis 2008, 14:1312-1314.
185. Higashiyama M., Ito T., Han X., Ono K., Minamimura K., Sakakibara F., et al. Epidural abscess caused by community-associated methicillin-resistant Staphylococcus aureus strain USA300 in Japan. J Infect Chemother 2010, 16:345-349.
186. Hung W.C., Mori H., Tsuji S., Iwao Y., Takano T., Nishiyama A., et al. Virulence gene and expression analysis of community-associated methicillin-resistant Staphylococcus aureus causing iliopsoas abscess and discitis with thrombocytopenia. J Infect Chemother 2013 Jan 31, [Epub ahead of print].
187. Mine Y., Higuchi W., Taira K., Nakasone I., Tateyama M., Yamamoto T., et al. Nosocomial outbreak of multidrug-resistant USA300 methicillin-resistant Staphylococcus aureus causing severe furuncles and carbuncles in Japan. J Dermatol 2011, 38:1167-1171.